Shkliaiev, S. (2019). Risk analysis for the definition of representative drug for the formation of the quality review at the pharmaceutical enterprise. Farmatsevtychnyi Zhurnal, (6), 26-29. Retrieved from https://pharmj.org.ua/index.php/journal/article/view/563